crizanlizumab
novartis
['crizanlizumab']
crizanlizumab may help significantly reduce painful priapic events in patients with #sicklecell. new data from #ash22 today: 
Breaking news, patient stories & FDA updates within the rare disease community. Listen to our podcast: https://t.co/xUkFDfCDUV, hosted by @GiulianaGrossi